Brief: Akoustis Reports Fiscal First Quarter 2022 Results
Nov 1 (Reuters) - Akoustis Technologies Inc AKTS.O :
* AKOUSTIS REPORTS FISCAL FIRST QUARTER 2022 RESULTS
* Q1 REVENUE ROSE 300 PERCENT TO $1.9 MILLION
* QTRLY NON-GAAP NET LOSS PER SHARE $0.21
* QTRLY LOSS PER SHARE $0.25
Source text for Eikon: ID:nGNXfq7q9
Further company coverage: AKTS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aktis Oncology
See all newsAktis Oncology Q2 net loss widens on higher R&D, administrative costs
U.S. RESEARCH ROUNDUP-Danaher, GM, MSCI
Aktis Oncology Q1 net loss widens on increased IPO-related expenses
Generate Biomedicines shares fall 6% in weak Nasdaq debut for drug developer (updated)
Flagship-backed Generate Biomedicines shares fall 6% in Nasdaq debut